Small, Long Blood Half-Life Iodine Nanoparticle for Vascular and Tumor Imaging

Abstract Standard clinical X-ray contrast agents are small iodine-containing molecules that are rapidly cleared by the kidneys and provide robust imaging for only a few seconds, thereby limiting more extensive vascular and tissue biodistribution imaging as well as optimal tumor uptake. They are also...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: James F. Hainfeld, Sharif M. Ridwan, Yaroslav Stanishevskiy, Nathaniel R. Smilowitz, James Davis, Henry M. Smilowitz
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
R
Q
Acceso en línea:https://doaj.org/article/e2691781666a4a66a77ed31f2d8a63c7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e2691781666a4a66a77ed31f2d8a63c7
record_format dspace
spelling oai:doaj.org-article:e2691781666a4a66a77ed31f2d8a63c72021-12-02T15:05:41ZSmall, Long Blood Half-Life Iodine Nanoparticle for Vascular and Tumor Imaging10.1038/s41598-018-31940-22045-2322https://doaj.org/article/e2691781666a4a66a77ed31f2d8a63c72018-09-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-31940-2https://doaj.org/toc/2045-2322Abstract Standard clinical X-ray contrast agents are small iodine-containing molecules that are rapidly cleared by the kidneys and provide robust imaging for only a few seconds, thereby limiting more extensive vascular and tissue biodistribution imaging as well as optimal tumor uptake. They are also not generally useful for preclinical microCT imaging where longer scan times are required for high resolution image acquisition. We here describe a new iodine nanoparticle contrast agent that has a unique combination of properties: 20 nm hydrodynamic diameter, covalent PEG coating, 40 hour blood half-life, 50% liver clearance after six months, accumulation in tumors, and well-tolerated to at least 4 g iodine/kg body weight after intravenous administration in mice. These characteristics are unique among the other iodine nanoparticles that have been previously reported and provide extended-time high contrast vascular imaging and tumor loading. As such, it is useful for preclinical MicroCT animal studies. Potential human applications might include X-ray radiation dose enhancement for cancer therapy and vascular imaging for life-threatening situations where high levels of contrast are needed for extended periods of time.James F. HainfeldSharif M. RidwanYaroslav StanishevskiyNathaniel R. SmilowitzJames DavisHenry M. SmilowitzNature PortfolioarticleLonger Blood Half-lifemicroCT ImagesTumour LoadLiver ClearanceHigh Resolution Image AcquisitionMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-10 (2018)
institution DOAJ
collection DOAJ
language EN
topic Longer Blood Half-life
microCT Images
Tumour Load
Liver Clearance
High Resolution Image Acquisition
Medicine
R
Science
Q
spellingShingle Longer Blood Half-life
microCT Images
Tumour Load
Liver Clearance
High Resolution Image Acquisition
Medicine
R
Science
Q
James F. Hainfeld
Sharif M. Ridwan
Yaroslav Stanishevskiy
Nathaniel R. Smilowitz
James Davis
Henry M. Smilowitz
Small, Long Blood Half-Life Iodine Nanoparticle for Vascular and Tumor Imaging
description Abstract Standard clinical X-ray contrast agents are small iodine-containing molecules that are rapidly cleared by the kidneys and provide robust imaging for only a few seconds, thereby limiting more extensive vascular and tissue biodistribution imaging as well as optimal tumor uptake. They are also not generally useful for preclinical microCT imaging where longer scan times are required for high resolution image acquisition. We here describe a new iodine nanoparticle contrast agent that has a unique combination of properties: 20 nm hydrodynamic diameter, covalent PEG coating, 40 hour blood half-life, 50% liver clearance after six months, accumulation in tumors, and well-tolerated to at least 4 g iodine/kg body weight after intravenous administration in mice. These characteristics are unique among the other iodine nanoparticles that have been previously reported and provide extended-time high contrast vascular imaging and tumor loading. As such, it is useful for preclinical MicroCT animal studies. Potential human applications might include X-ray radiation dose enhancement for cancer therapy and vascular imaging for life-threatening situations where high levels of contrast are needed for extended periods of time.
format article
author James F. Hainfeld
Sharif M. Ridwan
Yaroslav Stanishevskiy
Nathaniel R. Smilowitz
James Davis
Henry M. Smilowitz
author_facet James F. Hainfeld
Sharif M. Ridwan
Yaroslav Stanishevskiy
Nathaniel R. Smilowitz
James Davis
Henry M. Smilowitz
author_sort James F. Hainfeld
title Small, Long Blood Half-Life Iodine Nanoparticle for Vascular and Tumor Imaging
title_short Small, Long Blood Half-Life Iodine Nanoparticle for Vascular and Tumor Imaging
title_full Small, Long Blood Half-Life Iodine Nanoparticle for Vascular and Tumor Imaging
title_fullStr Small, Long Blood Half-Life Iodine Nanoparticle for Vascular and Tumor Imaging
title_full_unstemmed Small, Long Blood Half-Life Iodine Nanoparticle for Vascular and Tumor Imaging
title_sort small, long blood half-life iodine nanoparticle for vascular and tumor imaging
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/e2691781666a4a66a77ed31f2d8a63c7
work_keys_str_mv AT jamesfhainfeld smalllongbloodhalflifeiodinenanoparticleforvascularandtumorimaging
AT sharifmridwan smalllongbloodhalflifeiodinenanoparticleforvascularandtumorimaging
AT yaroslavstanishevskiy smalllongbloodhalflifeiodinenanoparticleforvascularandtumorimaging
AT nathanielrsmilowitz smalllongbloodhalflifeiodinenanoparticleforvascularandtumorimaging
AT jamesdavis smalllongbloodhalflifeiodinenanoparticleforvascularandtumorimaging
AT henrymsmilowitz smalllongbloodhalflifeiodinenanoparticleforvascularandtumorimaging
_version_ 1718388739483369472